BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6313188)

  • 1. Phase II study of oral medroxyprogesterone acetate in advanced germ cell tumors.
    Cavalli F; Klepp O; Hansen H; Rozencweig M
    Cancer Treat Rep; 1983 Oct; 67(10):953-4. PubMed ID: 6313188
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.
    Drasga RE; Williams SD; Einhorn LH; Birch R
    Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of testicular tumors].
    Cortes Funes H; Leiva Galvis O
    Actas Urol Esp; 1981; 5(5):259-72. PubMed ID: 6174033
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phase II study of medroxyprogesterone acetate in advanced breast cancer].
    Ueno K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nakamura T; Ito Y; Imajo K; Ozeki H
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3198-202. PubMed ID: 2946264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testicular tumors: delay in diagnosis and influence on survival.
    Prout GR; Griffin PP
    Am Fam Physician; 1984 May; 29(5):205-9. PubMed ID: 6328963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
    Williams SD; Birch R; Gams R; Irwin L
    Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
    Kjaer M; Frederiksen PL
    Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapeutic treatment regimens for germinal testicular tumors].
    Hofmann W; Langkopf B; Heinrichs HJ; Rebmann U
    Z Urol Nephrol; 1983 Nov; 76(11):741-50. PubMed ID: 6320553
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumors.
    Gold EJ; Bosl GJ; Itri LM
    Cancer Treat Rep; 1984 Oct; 68(10):1287-8. PubMed ID: 6098365
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II evaluation of oral medroxyprogesterone acetate in advanced breast cancer: a Northern California Oncology Group Study.
    Tan YO; Hendrickson C; McWhirter K; Kohler M; Hannigan JF; Carlson RW
    Cancer Treat Rep; 1987 Oct; 71(10):969-70. PubMed ID: 2958131
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of 1,2-diaminocyclohexane-(4-carboxyphthalato) platinum(II) in patients with refractory germ cell tumors.
    Chun H; Bosl GJ; Golbey RB
    Cancer Treat Rep; 1985 Apr; 69(4):459-60. PubMed ID: 2986834
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polychemotherapy of malignant tumors and hemoblastoses].
    Kühböck J; Pokorny D; Steinbach K; Eggerth G
    Wien Z Inn Med; 1968; 49(12):449-61. PubMed ID: 4311394
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results.
    Guarnieri A; Tucci E; D'Aniello C; Carli A; Mariani L; De Stefano A; Nardi P
    Chemioterapia; 1984 Oct; 3(5):320-3. PubMed ID: 6241848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT.
    Einhorn LH; Brames MJ; Heinrich MC; Corless CL; Madani A
    Am J Clin Oncol; 2006 Feb; 29(1):12-3. PubMed ID: 16462496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pain relief by high-dose medroxyprogesterone acetate in advanced prostatic cancer].
    Sasagawa I; Satomi S; Umeda K; Katayama T
    Hinyokika Kiyo; 1989 Apr; 35(4):603-8. PubMed ID: 2525316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germ cell tumors.
    Bajorin DF; Motzer RJ; Bosl GJ
    Curr Ther Endocrinol Metab; 1997; 6():387-92. PubMed ID: 9174777
    [No Abstract]   [Full Text] [Related]  

  • 17. [Excretion of estrogens and 17-ketosteroids in patients with different histological forms of testicular tumors before and during chemotherapy].
    Murav'eva NI; Smirnova KD; Sharoukhova KS; Shipilov VI
    Urol Nefrol (Mosk); 1978; (1):54-7. PubMed ID: 204094
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of malignant testicular tumors].
    Weissbach L; Jaeger N; Hartlapp JH; Boedefeld EA; Vahlensieck W
    Urologe A; 1983 Sep; 22 Suppl():310-21. PubMed ID: 6314621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral plus intramuscular medroxyprogesterone acetate (high dose Farlutal) in advanced breast cancer.
    Ngelangel CA; Jimenez MV; Villalon AH; Agustin BM
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):634-7. PubMed ID: 2940689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy of germ cell tumors of the testis with vincristine, adriamycin, cyclophosphamide, actinomycin D and medroxyprogesterone acetate.
    Klepp O; Klepp R; Host H; Asbjornsen G; Talle K; Stenwig AE
    Cancer; 1977 Aug; 40(2):638-46. PubMed ID: 70266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.